Data / New clinical trials / Alzheimer Disease

Alzheimer Disease trials: 556 new since Nov 2024

Name: New Alzheimer Disease clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Alzheimer Disease clinical trials: 556 rows for $27.80, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 25 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/alzheimer-disease, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

556 clinical studies in Alzheimer Disease were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 125 have an industry sponsor and 408 are recruiting or about to. The newest, NCT07926438, was posted on November 9, 2026: 40 Hz Audio-Visual Stimulation Therapy for AD (The First Affiliated Hospital of Xiamen University).

The request: Every new Alzheimer Disease clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

556New trials
125Industry sponsored
408Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 556, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926438	40 Hz Audio-Visual Stimulation Therapy for AD	The First Affiliated Hospital of Xiamen University	Not applicable	Not yet recruiting	Alzheimer's Disease Related Dementia	50	China	clinicaltrials.gov
November 6, 2026	NCT07923812	Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study	Fudan University	Observational	Recruiting	Alzheimer's Disease (AD)	3,000	China	clinicaltrials.gov
November 5, 2026	NCT07918534	Music Listening for Chronic Pain in Adults With Early-Stage Dementia	Florida State University	Not applicable	Not yet recruiting	Chronic Pain, Alzheimer Disease, Dementia	40		clinicaltrials.gov
November 5, 2026	NCT07918417	Exercise in Alzheimer's Disease: Functional Biomarkers	European University Miguel de Cervantes	Not applicable	Not yet recruiting	Alzheimer's Dementia (AD), Alzheimer Disease (AD)	48	Spain	clinicaltrials.gov
November 3, 2026	NCT07912736	BioMIND Biospecimen Repository	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Observational	Enrolling by invitation	Alzheimer's Disease (AD), Cognitive Impairment	1,000	Canada	clinicaltrials.gov
November 3, 2026	NCT07912710	China HEalthy Aging and Dementia Study (HEAD)	Fudan University	Observational	Recruiting	Alzheimer Disease (AD), Mild Cognitive Impairment (MCI), Dementia, Vascular Dementia (VaD), Cognitive Decline, Familial...	20,000	China	clinicaltrials.gov
October 30, 2026	NCT07906769	Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models	Istituti Clinici Scientifici Maugeri SpA	Not applicable	Recruiting	Alzheimer's Disease (AD), Frontotemporal Dementia (FTD), Parkinsons Disease (PD), Lewy Body Dementia	200	Italy	clinicaltrials.gov
October 30, 2026	NCT07906054	Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease	Universitaire Ziekenhuizen KU Leuven	Observational	Not yet recruiting	Alzheimer's Disease, Healthy Adult Participants	70	Belgium	clinicaltrials.gov
October 29, 2026	NCT07905352	A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease	Vigonvita Life Sciences	Phase 2	Not yet recruiting	Alzheimer Disease	200	China	clinicaltrials.gov
October 27, 2026	NCT07897708	A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older...	Pfizer	Phase 1	Not yet recruiting	Alzheimer Disease	98		clinicaltrials.gov
October 26, 2026	NCT07893678	Virtual Reality to Advance Dementia Care and Quality of Life	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Not applicable	Not yet recruiting	Dementia, Agitation, Behavioural and Psychological Symptoms of Dementia, Major Neurocognitive Disorder, Agitation...	10	Canada	clinicaltrials.gov
October 23, 2026	NCT07891429	Fuzhou Aging Brain Health Initiative	Fujian Medical University Union Hospital	Observational	Recruiting	Dementia, Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)	3,000	China	clinicaltrials.gov
October 22, 2026	NCT07889349	A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants	Beijing Suncadia Pharmaceuticals Co., Ltd	Phase 1	Not yet recruiting	Alzheimer's Disease	50	China	clinicaltrials.gov
October 20, 2026	NCT07883746	Remote Digital Assessments for Cognitive Disorders	Centre for Addiction and Mental Health	Observational	Not yet recruiting	Mild Cognitive Impairment (MCI), Alzheimer Disease (AD)	60	Canada	clinicaltrials.gov
October 20, 2026	NCT07883291	SmartEnLite for Nursing Home Residents With Dementia	Penn State University	Not applicable	Not yet recruiting	Alzheimer's Disease and Related Dementias, Alzheimer Disease and Related Dementias	300	United States	clinicaltrials.gov
October 20, 2026	NCT07883148	TPSAlz - Transcranial Pulse Stimulation in Alzheimer's Disease	IRCCS San Raffaele Roma	Not applicable	Completed	Alzheimer Disease, Mild Cognitive Impairment	52	Italy	clinicaltrials.gov
October 20, 2026	NCT07882251	Shedding Light on Dementia With Lewy Bodies: a Multimodal 'Bright Light Treatment' to Modulate Brain Functions	Azienda Usl di Bologna	Not applicable	Completed	Alzheimer Disease, Dementia, Brain Disorders, Lewy Bodies Disease	80	Italy	clinicaltrials.gov
October 19, 2026	NCT07880275	Clinical Cohort of Memory Disorders	Yonsei University	Observational	Recruiting	Neurodegenerative Disease, Mild Cognitive Impairmen, Dementia, Alzheimer Disease	1,550	South Korea	clinicaltrials.gov
October 15, 2026	NCT07876570	A Prospective Cohort Study of Multimodal Biomarkers and Progression From Mild Cognitive Impairment to Dementia	Xuanwu Hospital, Beijing	Observational	Recruiting	Mild Cognitive Impairment (MCI)	600	China	clinicaltrials.gov
October 14, 2026	NCT07873463	Flutemetamol F 18 Injection Formulation Comparison	GE Healthcare	Phase 2	Recruiting	Cognitive Dysfunction	20	United States	clinicaltrials.gov
October 14, 2026	NCT07872956	Feasibility Study of a Co-Designed Gamified Medical Yoga App for Home-Based Cancer Rehabilitation	Linkoeping University	Not applicable	Recruiting	Cancer	10	Sweden	clinicaltrials.gov
October 13, 2026	NCT07872072	HomeCare Medication Management for People With Dementia	HiDO Technologies	Not applicable	Not yet recruiting	Dementia, Alzheimer's Disease and Related Dementias	120	United States	clinicaltrials.gov
October 13, 2026	NCT07871487	Tau Pathology in the Brain After Hip or Knee Replacement Surgery	Uppsala University Hospital	Observational	Recruiting	Postoperative Cognitive Dysfunction, Alzheimer Disease, Tauopathies, Neuroinflammation, Arthroplasty, Replacement, Hip...	30	Sweden	clinicaltrials.gov
October 13, 2026	NCT07870070	Functionalized Point of Care and 3D Printed Dental Aligners as Devices for Early Detection of Neurodegenerative Diseases	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Observational	Active not recruiting	Neurodegenerative Diseases, Alzheimer's Disease	256	Italy	clinicaltrials.gov
October 9, 2026	NCT07869264	An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan	Eisai Taiwan Inc.	Observational	Not yet recruiting	Alzheimer's Disease	100	Taiwan	clinicaltrials.gov
October 9, 2026	NCT07869238	Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease	Neumous Inc.	Not applicable	Recruiting	Alzheimer's Disease, Blood Brain Barrier	10	South Korea	clinicaltrials.gov
October 8, 2026	NCT07866768	CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)	University of California, San Francisco	Not applicable	Recruiting	Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease	28	United States	clinicaltrials.gov
October 8, 2026	NCT07864623	A Postmarketing Study of LEQEMBI in Participants With Alzheimer's Disease	Eisai Inc.	Observational	Not yet recruiting	Alzheimers Disease	270	United States	clinicaltrials.gov
October 7, 2026	NCT07863011	Exploratory Study of Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Patients With Mild Alzheimer's Disease Dementia	ReadyCure Inc.	Not applicable	Recruiting	Alzheimer Disease	30	South Korea	clinicaltrials.gov
October 7, 2026	NCT07862244	A Grief Support App for Adults Experiencing Bereavement	Medical Research Council Cognition and Brain Sciences Unit	Not applicable	Not yet recruiting	Grief	80	United Kingdom	clinicaltrials.gov
October 5, 2026	NCT07859540	Negotiation Training for Family Caregivers of People With Alzheimer's Disease	Northwestern University	Not applicable	Not yet recruiting	Alzheimer's Disease (AD), Dementia, Cognitive Impairment	200	United States	clinicaltrials.gov
October 5, 2026	NCT07857759	Cervical Lymphatic Microsurgery in Alzheimer's Disease	Daniel Maliszewski	Not applicable	Recruiting	Alzheimer Disease	30	Poland	clinicaltrials.gov
October 2, 2026	NCT07854327	Restoring Cervical Lymphatic Drainage in Alzheimer's Disease	University of Siena	Not applicable	Recruiting	Alzheimer, Alzheimer Dementia (AD)	5	Italy	clinicaltrials.gov
September 29, 2026	NCT07846566	Choose Myself (Before) Losing Myself	The Cleveland Clinic	Not applicable	Recruiting	Dementia (Diagnosis), Mild Cognitive Impairment, Alzheimer's Disease Dementia, Alzheimer's Disease	25	United States	clinicaltrials.gov
September 28, 2026	NCT07843459	A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)	Eli Lilly and Company	Phase 1	Not yet recruiting	Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid, Plasma	111	China, Japan, United States	clinicaltrials.gov
September 25, 2026	NCT07842146	The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease	University Hospital, Akershus	Not applicable	Recruiting	Alzheimer's Disease (AD), Early Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease	60	Czechia	clinicaltrials.gov
September 24, 2026	NCT07839650	Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Alzheimer's Disease	IRCCS Centro San Giovanni di Dio Fatebenefratelli	Not applicable	Recruiting	Transcranial Alternating Current Stimulation, Alzheimer Disease (AD), Alzheimer Dementia (AD), Cognitive Rehabilitation	30	Italy	clinicaltrials.gov
September 24, 2026	NCT07839286	Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias	Callahan-Young LLC DBA Jigsawdio	Not applicable	Not yet recruiting	Alzheimer Disease, Dementia, Mild Cognitive Impairment	80	United States	clinicaltrials.gov
September 24, 2026	NCT07838155	A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease	Eli Lilly and Company	Phase 4	Not yet recruiting	Alzheimer Disease	50	India	clinicaltrials.gov
September 23, 2026	NCT07835568	Thrive at Home: A Virtual Reality Social Intervention for Older Adults	University of California, Santa Barbara	Not applicable	Not yet recruiting	Mental Health (Depression), Mental Health and General Well-being, Loneliness, Well Being, Caregiver Burden, Caregiver...	250		clinicaltrials.gov
September 22, 2026	NCT07835399	Efficacy and Safety of Photobiomodulation Therapy in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease	Jun Xu	Not applicable	Recruiting	Mild Cognitive Impairment (MCI), Mild Alzheimer Disease, Dementia	20	China	clinicaltrials.gov
September 22, 2026	NCT07833267	Cognition and Affective Research in China	Xuanwu Hospital, Beijing	Observational	Not yet recruiting	Neurodegenerative Disease, Dementia, Alzheimer's Disease, Parkinson's Disease, Mood Disorders, Depression, Anxiety...	3,000	China	clinicaltrials.gov
September 22, 2026	NCT07832383	Evaluation of NBI-1117567 in Participants With Mild to Moderate Alzheimer's Disease (AD) Taking a Background Acetylcholinesterase Inhibitor	Neurocrine Biosciences	Phase 2	Not yet recruiting	Alzheimer's Disease	135		clinicaltrials.gov
September 18, 2026	NCT07827768	AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease	Institute for Molecular Medicine	Phase 2	Not yet recruiting	Preclinical Alzheimer's Disease, Alzheimer Disease	160		clinicaltrials.gov
September 18, 2026	NCT07827196	Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial	Anhui Medical University	Not applicable	Recruiting	Transcranial Random Noise Stimulation (tRNS), Electroencephalography, Alzheimer Disease, BPSD (Behavioral and...	40	China	clinicaltrials.gov
September 18, 2026	NCT07826975	Assessment of Changes in Autonomy Through Analysis of Smartphone Usage Data in Patients With Alzheimer's Disease	Poitiers University Hospital	Observational	Not yet recruiting	Alzheimer Disease (AD)	100		clinicaltrials.gov
September 17, 2026	NCT07824245	Advancing Ethical Goals In Society Trial	Tufts Medical Center	Not applicable	Not yet recruiting	Advance Care Planning, Dementia, Alzheimer's Disease	12,174	United States	clinicaltrials.gov
September 17, 2026	NCT07824128	Adaptango Performance PRocess for Older Adults Community reHabilitation	Emory University	Not applicable	Not yet recruiting	Parkinson Disease, Mild Cognitive Impairment, Old Age; Dementia	120	United States	clinicaltrials.gov
September 16, 2026	NCT07821658	A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease	Eisai Inc.	Observational	Recruiting	Alzheimer's Disease	6,700	United States	clinicaltrials.gov
September 11, 2026	NCT07815132	Fractional CO₂ Laser for Primary Cutaneous Amyloidosis	Tanta University	Not applicable	Completed	Amyloid, Fractional, Laser	22	Egypt	clinicaltrials.gov
September 10, 2026	NCT07812480	Multimodal Biomarkers in Individual With Cognitive Impairment and Dementia	Assiut University	Observational	Not yet recruiting	Dementia Disorders, Mild Cognitive Impairment (MCI)	75		clinicaltrials.gov
September 10, 2026	NCT07812337	Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care	University of Wisconsin, Madison	Not applicable	Recruiting	Cognitive Abnormality	70	United States	clinicaltrials.gov
September 3, 2026	NCT07803055	Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Recruiting	Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease, Alzheimer's Disease...	48	Italy	clinicaltrials.gov
September 2, 2026	NCT07799402	Microbiome in Aging of Gut and Brain	University of South Florida	Observational	Recruiting	Mild Cognitive Impairment, Alzheimer Disease (AD), Dementia	700	United States	clinicaltrials.gov
September 1, 2026	NCT07798700	Biofluid Research on Age-Related or Inherited Neurodegeneration	University of Pennsylvania	Observational	Recruiting	Frontotemporal Degeneration (FTD), ALS (Amyotrophic Lateral Sclerosis), Primary Progressive Aphasia (PPA), Familial...	1,000	United States	clinicaltrials.gov
September 1, 2026	NCT07796308	Terazosin And Metabolic Engagement in Alzheimer's Disease	Qiang Zhang	Phase 2	Not yet recruiting	Alzheimer s Disease	100	United States	clinicaltrials.gov
August 31, 2026	NCT07795307	Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease	Brigham and Women's Hospital	Phase 1	Not yet recruiting	Alzheimer's Disease	20	United States	clinicaltrials.gov
August 31, 2026	NCT07794670	Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease	NewAmsterdam Pharma	Phase 2	Recruiting	Preclinical Alzheimer's Disease	400	United States	clinicaltrials.gov
August 26, 2026	NCT07787182	A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease	Eli Lilly and Company	Phase 1	Recruiting	Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid	68	China, Japan, United States	clinicaltrials.gov
August 26, 2026	NCT07787169	A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease	Eli Lilly and Company	Phase 1	Recruiting	Alzheimer Disease, Amyloid, Plaque, Amyloid, Healthy Volunteers	179	China, Japan, United States	clinicaltrials.gov
August 25, 2026	NCT07786116	The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions	University of Cambridge	Not applicable	Recruiting	PARKINSON DISEASE (Disorder), Parkinson, Parkinson Disease, Parkinson s Disease, REM Behavior Disorder, REM Sleep...	215	United Kingdom	clinicaltrials.gov
August 24, 2026	NCT07781657	Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease	Hoffmann-La Roche	Phase 2	Recruiting	Alzheimer's Disease	450	Australia, France, United States	clinicaltrials.gov
August 24, 2026	NCT07781345	A Postmarketing Study of LEQEMBI in United Kingdom (UK) Participants With Alzheimer's Disease (AD)	Eisai Limited	Observational	Not yet recruiting	Alzheimers Disease	400	United Kingdom	clinicaltrials.gov
August 21, 2026	NCT07780383	A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in...	Bristol-Myers Squibb	Phase 1	Recruiting	Alzheimer's Disease, Healthy Participants	84	United States	clinicaltrials.gov
August 21, 2026	NCT07779863	Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease	The University of Hong Kong	Not applicable	Not yet recruiting	Alzheimer's Disease	188	Hong Kong	clinicaltrials.gov
August 21, 2026	NCT07779785	VICA: A Virtual Care Assistant for Dementia Caregivers	Indiana University	Not applicable	Not yet recruiting	Alzheimer Dementia (AD), Caregiver Burden of People With Dementia	120	United States	clinicaltrials.gov
August 20, 2026	NCT07775625	Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music	Northwestern University	Not applicable	Recruiting	Alzheimer's Disease	30	United States	clinicaltrials.gov
August 20, 2026	NCT07775196	Aging and Exercise Impacts on Glymphatic Function	University of Texas Southwestern Medical Center	Not applicable	Not yet recruiting	Aging and Exercise Impacts on Glymphatic Function	240		clinicaltrials.gov
August 19, 2026	NCT07773493	A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement	University of Minnesota	Not applicable	Not yet recruiting	Memory Disorders, Mild Cognitive Impairment, Dementia, Social Isolation, Caregiver Burden	200	United States	clinicaltrials.gov
August 17, 2026	NCT07768592	A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease...	Eisai Inc.	Phase 1	Not yet recruiting	Alzheimers Disease	32		clinicaltrials.gov
August 17, 2026	NCT07768579	The Effect of Sequential Therapy on Alzheimer's Disease	Dongzhimen Hospital, Beijing	Observational	Recruiting	Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease	600	China	clinicaltrials.gov
August 14, 2026	NCT07766174	Transforming Maternal Mental Health Care	University of Utah	Not applicable	Recruiting	Perinatal Mental Health	50	United States	clinicaltrials.gov
August 13, 2026	NCT07763392	Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan	The Neurology Center of Southern California	Observational	Recruiting	Cognition, Cognition Disorders, Cognition - Other, Dementia, Alzheimer Disease, Memory, Neurocognition	1,000	United States	clinicaltrials.gov
August 13, 2026	NCT07762092	A Post Authorization Registry Study of Participants Treated With LEQEMBI	Eisai Limited	Observational	Recruiting	Alzheimers Disease	400	Canada	clinicaltrials.gov
August 11, 2026	NCT07758751	Multisensory 40-Hz Stimulation for Alzheimer's Disease	Beijing Tiantan Hospital	Not applicable	Not yet recruiting	Alzheimer Disease	60		clinicaltrials.gov
August 11, 2026	NCT07758660	Alzheimer's Disease Research Center (ADRC) PET Component Study	Patrick Lao	Phase 2	Enrolling by invitation	Alzheimer Disease, Mild Cognitive Impairment (MCI), Dementia	120	United States	clinicaltrials.gov
August 11, 2026	NCT07758595	A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's...	Denali Therapeutics Inc.	Phase 1	Recruiting	Alzheimer's Disease, Healthy Participants	178	United Kingdom	clinicaltrials.gov
August 11, 2026	NCT07757204	An Open-label Long-term Safety Study of Buntanetap in Participants With AD	Annovis Bio Inc.	Phase 2/3	Not yet recruiting	Alzheimer's Dementia (AD)	400		clinicaltrials.gov
August 11, 2026	NCT07757178	Lived Experience Narratives in Dementia	University of Nottingham	Not applicable	Recruiting	Dementia, Neuro-Degenerative Disease, Alzheimer Disease, Caregiver Burden, Caregiver Burnout	60	United Kingdom	clinicaltrials.gov
August 10, 2026	NCT07756294	Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease	Wake Forest University Health Sciences	Phase 2	Not yet recruiting	Alzheimer Disease	30	United States	clinicaltrials.gov
August 7, 2026	NCT07752784	Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV...	JYAMS PET Research & Development Limited	Phase 3	Recruiting	Alzheimer's Disease	12	China	clinicaltrials.gov
August 3, 2026	NCT07741071	N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease	Haukeland University Hospital	Phase 2	Recruiting	Alzheimer Disease (AD)	270	Norway	clinicaltrials.gov
July 29, 2026	NCT07732842	Study of Repetitive Behaviors in Alzheimer's Disease	Centre Hospitalier Esquirol	Observational	Recruiting	Alzheimer Disease, Anterograde Amnesia, Anosognosia	103	France	clinicaltrials.gov
July 28, 2026	NCT07730671	PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers	Barcelonabeta Brain Research Center, Pasqual Maragall Foundation	Observational	Not yet recruiting	Subjective Cognitive Decline (SCD)	121	Spain	clinicaltrials.gov
July 23, 2026	NCT07723950	A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's...	Eisai Inc.	Observational	Active not recruiting	Alzheimer's Disease	600	United States	clinicaltrials.gov
July 23, 2026	NCT07722169	Telerehabilitation in Alzheimer's Disease	IRCCS San Raffaele	Not applicable	Not yet recruiting	Alzheimer	48		clinicaltrials.gov
July 23, 2026	NCT07721701	Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild...	University of Erlangen-Nürnberg Medical School	Observational	Recruiting	Mild Cognitive Disorder, Alzheimer Disease, Vascular Dementia, Dementia in Other Diseases Classified Elsewhere...	5,000	Germany	clinicaltrials.gov
July 23, 2026	NCT07721467	Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin	National Institute on Aging (NIA)	Phase 2	Recruiting	Alzheimer's Disease	200	United States	clinicaltrials.gov
July 22, 2026	NCT07720765	Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)	IRCCS San Raffaele	Observational	Recruiting	Multiple Sclerosis, Alzheimer Disease, Parkinson Disease, Migraine, Headache Disorders	1,050	Italy	clinicaltrials.gov
July 21, 2026	NCT07717567	Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression	IRCCS San Raffaele	Observational	Recruiting	Alzheimer Disease, Mild Cognitive Impairment, Subjective Cognitive Decline, Dementia, Cognitive Impairment	2,000	Italy	clinicaltrials.gov
July 21, 2026	NCT07717411	A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease	Hoffmann-La Roche	Phase 3	Recruiting	Alzheimer's Disease	1,600	Argentina, Australia, Brazil, Canada, Chile, China, Japan, Taiwan, United...	clinicaltrials.gov
July 16, 2026	NCT07708675	Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - EU	MMI (Medical Microinstruments, Inc.)	Not applicable	Not yet recruiting	Alzheimer's	50		clinicaltrials.gov
July 14, 2026	NCT07701161	Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device	Neurogen Biomarking LLC	Observational	Recruiting	Alzheimer s Disease, MCI Conversion to Dementia, pTau217, Biomarkers	1,000	United States	clinicaltrials.gov
July 13, 2026	NCT07698431	Personalized Brain Health Service and Dementia Prevention	Barcelonabeta Brain Research Center, Pasqual Maragall Foundation	Not applicable	Recruiting	Subjective Cognitive Decline (SCD)	120	Spain	clinicaltrials.gov
July 13, 2026	NCT07697664	Moving Yourself in Space and Time: MYSTIC	Emory University	Not applicable	Recruiting	Parkinson's Disease (PD), Alzheimer's Disease (AD) and Related Disorders, Older Adults (60 - 85 Years Old)	210	United States	clinicaltrials.gov
July 10, 2026	NCT07695701	Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis	Eidos Therapeutics, a BridgeBio company	Phase 4	Recruiting	Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis	150	United States	clinicaltrials.gov
July 10, 2026	NCT07694921	Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease	First Affiliated Hospital of Zhejiang University	Not applicable	Enrolling by invitation	Alzheimer's Disease(AD)	30	China	clinicaltrials.gov
July 9, 2026	NCT07693140	Low-Dose Radiotherapy for Alzheimer's Disease	Evan Thomas	Phase 1/2	Recruiting	Alzheimer Dementia, Dementia, Alzheimer Dementia (AD), Alzheimer, Alzheimer s Disease	50	United States	clinicaltrials.gov
July 8, 2026	NCT07690865	Investigating the Effectiveness of Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function Enhancement	Chang Gung Memorial Hospital	Not applicable	Not yet recruiting	Gamma Oscillations, Healthy Adults, Alzheimer's Disease (AD), Gamma Entrainment Using Sensory Stimuli (GENUS)	20	Taiwan	clinicaltrials.gov
July 8, 2026	NCT07690228	A Study of GSM-779690T in Healthy Adult Participants	Acta Pharmaceuticals	Phase 1	Not yet recruiting	Healthy Adult Participants, Alzheimer Disease	72	Australia	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Eli Lilly and Company	10	September 28, 2026
Xuanwu Hospital, Beijing	9	October 15, 2026
IRCCS San Raffaele	8	July 23, 2026
Bristol-Myers Squibb	7	August 21, 2026
Hoffmann-La Roche	6	August 24, 2026
Northwestern University	5	October 5, 2026
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	5	January 21, 2026
Universitaire Ziekenhuizen KU Leuven	4	October 30, 2026
Eisai Inc.	4	October 8, 2026
Beijing Tiantan Hospital	4	August 11, 2026
Yale University	4	May 22, 2026
Imperial College London	4	February 11, 2026
Central Hospital, Nancy, France	4	December 30, 2025
Tianjin Medical University	4	December 29, 2025
I.R.C.C.S. Fondazione Santa Lucia	4	July 20, 2025
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	3	November 3, 2026
IRCCS San Raffaele Roma	3	October 20, 2026
University of California, San Francisco	3	October 8, 2026
Emory University	3	September 17, 2026
University of Wisconsin, Madison	3	September 10, 2026

By phase

Phase	New trials	Latest
Not applicable	252	November 9, 2026
Observational	143	November 6, 2026
Phase 2	61	October 29, 2026
Phase 1	40	October 27, 2026
Phase 3	27	August 7, 2026
Phase 4	11	September 24, 2026
Phase 1/2	11	July 9, 2026
Early phase 1	7	January 7, 2026
Phase 2/3	4	August 11, 2026

By country

Country	New trials	Latest
United States	178	October 20, 2026
China	89	November 9, 2026
Italy	49	October 30, 2026
Spain	40	November 5, 2026
France	35	August 24, 2026
Canada	33	November 3, 2026
United Kingdom	27	October 7, 2026
South Korea	24	October 19, 2026
Australia	22	August 24, 2026
Taiwan	20	October 9, 2026
Japan	19	September 28, 2026
Germany	18	July 23, 2026
Netherlands	16	July 2, 2026
Poland	15	October 5, 2026
Argentina	14	July 21, 2026
Brazil	12	July 21, 2026
Czechia	11	September 25, 2026
Turkey (Türkiye)	11	June 5, 2026
Sweden	9	October 14, 2026
Belgium	8	October 30, 2026
Portugal	8	October 9, 2025
Norway	7	August 3, 2026
Greece	7	December 17, 2025
Chile	6	July 21, 2026
Puerto Rico	6	May 22, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.